A
41
5
UA
59
14
HAL
60
2
RHI
57
3
ETN
79
4
HPE
61
6
ESS
64
4
SIG
49
6
CMG
67
3
CTSH
54
-2
LMT
32
-12
AN
54
4
EXPE
91
3
OKE
81
3
MAS
56
5
UPS
51
10
BSX
70
2
MLM
51
3
DRI
48
3
TRV
56
3
A
41
5
UA
59
14
HAL
60
2
RHI
57
3
ETN
79
4
HPE
61
6
ESS
64
4
SIG
49
6
CMG
67
3
CTSH
54
-2
LMT
32
-12
AN
54
4
EXPE
91
3
OKE
81
3
MAS
56
5
UPS
51
10
BSX
70
2
MLM
51
3
DRI
48
3
TRV
56
3
Financhill
Back

Edesa Biotech 10K Form

Sell
19

EDSA
Edesa Biotech

Last Price:
2.11
Seasonality Move:
5.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDSA News And Ratings

See the #1 stock for the next 7 days that we like better than EDSA

EDSA Financial Statistics

Sales & Book Value

Annual Sales: $328.8K
Cash Flow: $-856.5K
Price / Cash Flow: 0
Annual Sales: $0.88
Price / Book: 2.39

Profitability

EPS (TTM): -2.19940
Net Income (TTM): $-6.93M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Edesa Biotech Earnings Forecast

Key Edesa Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for EDSA have been equal to 1,028.77% of Gross Profit Margin.
  • The Interest Expense is -0.63% of Operating Income.
  • Per Share Earnings over the last 15 years have been positive in 4 years.

Edesa Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDSA
CUSIP: 27966L
Website: edesabiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDSA Technical Analysis vs Fundamental Analysis

Sell
19
Edesa Biotech (EDSA) is a Sell

Is Edesa Biotech a Buy or a Sell?

  • Edesa Biotech stock is rated a Sell
    The current Edesa Biotech [EDSA] share price is $2.11. The Score for EDSA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.